Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
VANDETANIB
Caprelsa
Prostate Cancer
D4200L00010ZENITHNCT00686036Tabulated Results
VANDETANIB
Caprelsa
Lung Cancer
D4200L00012ZELIGNCT00753714Tabulated Results
VANDETANIB
Caprelsa
Thyroid Cancer
LPS14809NANCT01496313Tabulated Results
VANDETANIB
Caprelsa
Prostate Cancer
LPS14813NANCT01876784Tabulated Results
VANDETANIB
Caprelsa
Thyroid Cancer
LPS14940NANCT00537095Tabulated Results
VANDETANIB
Caprelsa
Metastatic Medullary Thyroid Cancer
OBS14778NANCT01945762Abstract
VENGLUSTAT
Not marketed
Fabry Disease
ACT13739NAEudraCT: 2013-005324-41Tabulated Results
VENGLUSTAT
Not marketed
Parkinson's Disease
ACT14820MOVES-PDNCT02906020Tabulated Results
VENGLUSTAT
Not marketed
Polycystic kidney, autosomal dominant
EFC15392STAGED-PKDNCT03523728Tabulated Results
VENGLUSTAT
Not marketed
Fabry Disease
LTS14116NANCT02489344Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted